XXII not only has plant science technology to grow low-nicotine tobacco, it has technology to grow cannabis with varying levels of CBDs and zero-THC
XXII discontinued selling cigarettes in the USA EOY/17.
It seems that their low-nicotine Tobacco patents may be in competition with old patents owned by large Tobacco companies. Specifically, Burley varieties of tobacco were developed with this trait many decades ago.
XXII are part owners with ACBFF of a cannabis research laboratory
Their Botantical Genetics division has developed technology for zero-THC Hemp.
It is not uncommon for Hemp farmers to grow a field of Hemp only to find out that the crop exceeds regulatory levels to be recognized as Hemp and must be disposed of.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.